Jihao Zhou

6PUBLICATIONS
65CO-AUTHORS
Molecular targetsImmunology not elsewhere classifiedTumour immunologyClinimetricsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2026
The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

|Aug 21, 2026
Hypoplastic acute myeloid leukemia with aberrant lymphoid antigen expression and EWSR1::FEV fusion: A rare case report and literature review.

|Jul 23, 2026
Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T-Cell Lymphoma: A Real-World National Cancer Database Study.

|Jun 23, 2026
A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis.

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Sep 23, 2022
TAFRO syndrome: A disease that known is half cured.

Tingting Chen, Chun Feng, Xinyou Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Yucai Wang

1 joint publications

Edward R Scheffer Cliff

1 joint publications

Guido D Pelaez

1 joint publications

Fei Wan